[01] Nadia Begum, Institute of Nutrition and Food Science, University of Dhaka, Dhaka, Bangladesh; Department of Community Medicine, Z. H Sikder Women’s Medical College, Dhaka, Bangladesh. [02] Sneha Sarwar, Institute of Nutrition and Food Science, University of Dhaka, Dhaka, Bangladesh. [03] Ahmed Jubayer, Institute of Nutrition and Food Science, University of Dhaka, Dhaka, Bangladesh. [04] Monowar Ahmad Tarafdar, Department of Community Medicine, Z. H Sikder Women’s Medical College, Dhaka, Bangladesh. [05] Nazrul Islam Khan, Institute of Nutrition and Food Science, University of Dhaka, Dhaka, Bangladesh. [06] Sheikh Nazrul Islam, Institute of Nutrition and Food Science, University of Dhaka, Dhaka, Bangladesh.

Background: Vitamin D deficiency is prevalent in type 2 diabetes and this vitamin may be related to insulin action which may facilitate insulin function by regulating its receptor expression, responsible for increasing insulin sensitivity. Therefore, the correction of vitamin D deficiency may result in improved glucose control as well has beneficial effects on complications of diabetes type 2. The principal aim of this study was to describe socio-demographic and biochemical profile of type 2 diabetic patient as well as to find out the effect of socio-demographic factors on different biochemical profiles of those diabetic persons. Method: The study was conducted on 45 type 2 diabetic patients (30 treatment group and 15 placebo group) undergoing vitamin D supplementation, who were recruited from specific health care center. Socio demographic data were collected using a structured pretested printed questionnaire by interviewing the subjects. Biochemical parameters were analyzed by spectroscopic methods using standard laboratory kits. SPSS software package version 21 was used to analyze the data. Results: Most of bio-chemical profiles were found to be improving following vitamin D supplementation Calcium and C-reactive protein become significantly changed (<0.005). Sex, age, education were significantly associated with CRP level (either on baseline or end line), whereas, Sex and BMI were found to be associated with HbA₁C at baseline, Calcium was associated with BMI at end line. Conclusion: We can conclude that socio demographic profile might have influence on the biochemical profile of type 2 diabetes.

Socio Demography, Biochemical Profile, Type 2 Diabetes Mellitus, BMI

[01] S. L. James et al., “Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017,” Lancet, vol. 392, no. 10159, pp. 1789–1858, Nov. 2018, doi: 10.1016/S0140-6736(18)32279-7. [02] R. Jayawardena, P. Ranasinghe, N. M. Byrne, M. J. Soares, P. Katulanda, and A. P. Hills, “Prevalence and trends of the diabetes epidemic in South Asia: A systematic review and meta-analysis,” BMC Public Health, vol. 12, no. 1, p. 380, Dec. 2012, doi: 10.1186/1471-2458-12-380. [03] J. Beckman, Global E&P, vol. 76, no. 7. 2016. [04] A. Alwan et al., “Global status report on noncommunicable diseases 2010,” 2010. [05] A. Mohiuddin, “Diabetes Fact: Bangladesh Perspective,” Int. J. Diabetes Res., vol. 2, no. 1, pp. 14–20, Feb. 2019, doi: 10.17554/IJDR.V2I1.2457. [06] N. van Schoor and P. Lips, “Global Overview of Vitamin D Status,” Endocrinology and Metabolism Clinics of North America, vol. 46, no. 4. W. B. Saunders, pp. 845–870, 01-Dec-2017, doi: 10.1016/j.ecl.2017.07.002. [07] S. Akhtar, “Vitamin D Status in South Asian Populations – Risks and Opportunities,” Crit. Rev. Food Sci. Nutr., vol. 56, no. 11, pp. 1925–1940, Aug. 2016, doi: 10.1080/10408398.2013.807419. [08] C. Mathieu, C. Gysemans, A. Giulietti, and R. Bouillon, “Vitamin D and diabetes,” Diabetologia, vol. 48, no. 7. Diabetologia, pp. 1247–1257, Jul-2005, doi: 10.1007/s00125-005-1802-7. [09] N. Begum et al. “Vitamin D status among Type 2 Diabetes Mellitus: An Observational Study Nadia,” Int. J. Adv. Res. Biol. Sci, vol. 8, no. 4, pp. 37–43, 2021, doi: 10.22192/ijarbs. [10] T. A. Alaidarous, N. M. Alkahtani, G. S. Aljuraiban, and M. M. A. Abulmeaty, “Impact of the Glycemic Control and Duration of Type 2 Diabetes on Vitamin D Level and Cardiovascular Disease Risk,” J. Diabetes Res., vol. 2020, 2020, doi: 10.1155/2020/8431976. [11] W. Alan, Tietz Clinical Guide to Laboratory Tests. W. B. Saunders, 2006. [12] K. Hutchinson, M. Healy, V. Crowley, M. Louw, and Y. Rochev, “Verification of Abbott 25-OH-vitamin D assay on the architect system,” Pract. Lab. Med., vol. 7, pp. 27–35, Apr. 2017, doi: 10.1016/j.plabm.2017.01.001. [13] M. Moriyama, N. Hayashi, C. Ohyabu, M. Mukai, S. Kawano, and S. Kumagai, “Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay,” Clin. Chem., vol. 52, no. 7, pp. 1423–1426, Jul. 2006, doi: 10.1373/clinchem.2005.065995. [14] M. Thevarajah, M. N. Nadzimah, and Y. Y. Chew, “Interference of hemoglobinA1c (HbA1c) detection using ion-exchange high performance liquid chromatography (HPLC) method by clinically silent hemoglobin variant in University Malaya Medical Centre (UMMC)-A case report,” Clin. Biochem., vol. 42, no. 4–5, pp. 430–434, Mar. 2009, doi: 10.1016/j.clinbiochem.2008.10.015. [15] R. Rao, S. Nayak, A. Pandey, and S. Kamath, “Diagnostic performance of C-reactive protein level and its role as a potential biomarker of severe dengue in adults,” Asian Pac. J. Trop. Med., vol. 13, no. 8, p. 358, Aug. 2020, doi: 10.4103/1995-7645.289440. [16] A. A. Krishnan and E. W. William, “Vitamin D and Glycemic Control in Impaired Fasting Glycemia,” 2014. [17] A. C. Anyanwu, O. A. Fasanmade, I. A. Odeniyi, S. Iwuala, H. B. Coker, and A. E. Ohwovoriole, “Effect of Vitamin D supplementation on glycemic control in Type 2 diabetes subjects in Lagos, Nigeria,” Indian J. Endocrinol. Metab., vol. 20, no. 2, pp. 189–194, Mar. 2016, doi: 10.4103/2230-8210.176345. [18] A. Kruit and P. Zanen, “The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases,” Clin. Biochem., vol. 49, no. 7–8, pp. 534–537, May 2016, doi: 10.1016/j.clinbiochem.2016.01.002. [19] K. Nakajima and K. Suwa, “Excess body weight affects HbA1c progression irrespective of baseline HbA1c levels in Japanese individuals: A longitudinal retrospective study,” Endocr. Res., vol. 40, no. 2, pp. 63–69, May 2015, doi: 10.3109/07435800.2014.934962. [20] H. Schlenz et al., “C-reactive protein reference percentiles among pre-adolescent children in Europe based on the IDEFICS study population,” Int. J. Obes., vol. 38, pp. S26–S31, Sep. 2014, doi: 10.1038/ijo.2014.132. [21] G. Y. Dinwiddie, R. E. Zambrana, L. A. Doamekpor, and L. Lopez, “The impact of educational attainment on observed race/ethnic disparities in inflammatory risk in the 2001–2008 national health and nutrition examination survey,” Int. J. Environ. Res. Public Health, vol. 13, no. 1, pp. 1–13, 2015, doi: 10.3390/ijerph13010042.